好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Movement Disorders: Parkinsonian Disorders

Thursday 04/29/04
03:45 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Movement Disorders
No CME available
Event Timeline
03:45 PM - 05:00 PM Abstract 001 - Route-Following and Safety Errors in Drivers with Parkinson[rsquo]s Disease
03:45 PM - 05:00 PM Abstract 002 - Cerebral White Matter Hyperintensities and Cortical Acetylcholinesterase Activity in Parkinsonian Dementia
03:45 PM - 05:00 PM Abstract 003 - Diffusion Tensor Imaging Demonstrates Differential Involvement of Brain Stem Structures in MSA and PSP
03:45 PM - 05:00 PM Abstract 004 - Acetylcholinesterase Inhibitors in Parkinson's Disease with Dementia: A Clinical and Brain Perfusional Study
03:45 PM - 05:00 PM Abstract 005 - A Double-Blind, Placebo-Controlled Trial of Donepezil in Patients with Parkinson's Disease and Related Dementia
Faculty Disclosures
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Richard B. Dewey, Jr., MD, FAAN Dr. Dewey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Dewey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Dewey has received research support from NINDS.
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Elaine Wyllie, MD Dr. Wyllie has received publishing royalties from a publication relating to health care.
Elia M. Pestana Knight, MD Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Pestana Knight has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus Pharmaceuticals.
Andrew Zeft No disclosure on file
David Bar-Or David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Sung M. Cho, DO Dr. Cho has nothing to disclose.
No disclosure on file
PHILLIP L. PEARL, MD, FAAN Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Stanton B. Elias, MD No disclosure on file
Meheroz H. Rabadi, MD, FAAN No disclosure on file
Gajja S. Salomons No disclosure on file
Muhammad Affan, MD Dr. Affan has nothing to disclose.
Ryan M. Hodgeman No disclosure on file
Naveen Sankhyan, MD, MBBS, DM The institution of Dr. Sankhyan has received research support from PTC Therapeutics for a Multicentric RCT. Dr. Sankhyan has received research support from Institute Grant, PGIMER, (Goverment Entity).
Mohammed A. Almuqbil, MD, FAAN No disclosure on file
Mohammed Kananeh, MD Dr. Kananeh has nothing to disclose.